Philips Respironics has recalled certain V60 and V60 Plus ventilators because some of them could stop working due to an expired adhesive, the Food and Drug Administration announced this week. FDA has identified this as a Class 1 recall, the most serious type because it may cause serious injury or death. No injuries or adverse health consequences have been reported. 

In other news, Adamis Pharmaceuticals Corp. has recalled certain lots of epinephrine injection, an emergency treatment for allergic reactions, because the needle may clog and prevent the drug from dispensing. Health care providers may report associated adverse reactions or quality problems to the FDA's MedWatch program.

Related News Articles

Headline
Kelley Sava, associate vice president of simulation at Advocate Health, and Brian Bjoern, M.D., patient safety manager at Laerdal Medical, share how simulation…
Headline
The Food and Drug Administration has identified a Class I recall of Abiomed Automated Impella Controllers due to the potential for serious injury or death. The…
Headline
The Food and Drug Administration yesterday announced that Olympus issued a global recall of its ViziShot 2 FLEX needles manufactured prior to May 12 following…
Headline
The Food and Drug Administration has identified a Class I recall for Mo-Vis BVBA R-net Joysticks due to a firmware error that causes the wheelchair to ignore…
Headline
The Food and Drug Administration has identified Class I recalls for the following products due to the potential for serious injury or death:Certain lots of…
Headline
The Food and Drug Administration has identified a Class I recall of Philips Respironics V30, A30 and A40 ventilators due to the potential for serious injury or…